Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
agreed, American, array, awar, behalf, BioEducation, Brazilian, buy, cl, closing, collateral, collateralized, component, consulting, core, customary, detail, detection, ding, economically, ese, Euro, expiration, external, force, gene, global, hedging, imaging, infrastructure, inical, Invitrogen, joinder, July, lea, Lif, maximum, merger, microbiology, multianalyte, multiplex, North, opposing, organizational, overhead, prejudgment, project, Proxy, real, se, sequential, shift, slightly, stopped, Submission, subsidiary, sufficient, uncollectible, unhedged, viable, warehouse, weexperienced
Removed:
decreased, month, software
Filing tables
Filing exhibits
Related press release
BIO similar filings
Filing view
External links
Exhibit 32.2
Certification of Periodic Report
I, Christine A. Tsingos, Chief Financial Officer of Bio-Rad Laboratories, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:
(1)
the Quarterly Report on Form 10-Q of the Company for the quarterly period ended June 30, 2005 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: | August 8, 2005 | /s/ Christine A. Tsingos | |
Christine A. Tsingos | |||
Vice President, Chief Financial Officer |